slides · global inventory
Legend
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 13,863
Current window 10,741-10,770
Pages 463
Rows per page 30
Component
10,741-10,770 of 13,863
09
The slide uses a grid-based layout to organize drug candidates by development stage. It includes a legend for '# Partnered and/or in collaboration' and a yellow dot for 'Precision medicine approach being explored'.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
10
The slide uses a timeline-like structure to categorize drug development projects by clinical phase.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
11
The slide uses a Kanban-style board to visualize drug development stages.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
12
The slide uses a color-coded system to distinguish between Oncology, Biopharmaceuticals, and Rare Disease designations.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
19
The slide uses a matrix-like structure to map drug candidates against therapeutic areas and treatment strategies.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations Loop · Voice Of Customer1 hit
20
The chart is a stacked bar chart comparing two periods. The legend order in the chart (APAC, EMEA, NA) corresponds to the colors red, grey, and black respectively.Canada Goose | Results Presentation Deck | 26 slides · Canada Goose
Conference presentation Investor relations Beat · Financials1 hit
03
The chart highlights the year-over-year dilution of common stock.Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations 1 hit
06
The chart uses a dual-axis approach (bars for absolute dollar value, dots for margin percentage).Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations 1 hit
10
The slide highlights the impact of an FLC accounting change and the exclusion of Farfetch on the reported metrics.Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations 1 hit
05
The slide uses a dashed green oval to emphasize the margin expansion delta.Starboard Value | Activist Presentation Deck | 14 slides · Starboard Value
Activist deck Activist investor Beat · Problem & ComplicationLoop · Benchmark Gap1 hit
38
The slide uses visual annotations (arrows and dashed circles) to suggest a path for valuation expansion for KVUE.Starboard Value | Activist Presentation Deck | 71 slides · Starboard Value
Activist deck Activist investor Loop · Cost Of Inaction1 hit
43
Uses a bar chart with horizontal reference lines to illustrate the drag effect of a specific business unit.Starboard Value | Activist Presentation Deck | 71 slides · Starboard Value
Activist deck Activist investor Loop · Cost Of Inaction1 hit
46
The chart highlights KVUE SH&B in red to emphasize its underperformance relative to the peer median.Starboard Value | Activist Presentation Deck | 71 slides · Starboard Value
Activist deck Activist investor Loop · Cost Of Inaction1 hit
63
The slide uses a regression line to highlight Kenvue's position below the trend line, indicating undervaluation.Starboard Value | Activist Presentation Deck | 71 slides · Starboard Value
Activist deck Activist investor Loop · Quick Win Big Bet1 hit
66
The slide uses a waterfall-like bridge to show the potential impact of Kenvue's Skin Health & Beauty segment growing at the end-market rate.Starboard Value | Activist Presentation Deck | 71 slides · Starboard Value
Activist deck Activist investor Loop · Quick Win Big Bet1 hit
67
The slide uses a regression line to show the valuation gap for Kenvue (KVUE) relative to its peer group.Starboard Value | Activist Presentation Deck | 71 slides · Starboard Value
Activist deck Activist investor Loop · Quick Win Big Bet1 hit
69
The chart uses a dashed line to indicate the peer median of 20%.Starboard Value | Activist Presentation Deck | 71 slides · Starboard Value
Activist deck Activist investor Loop · Quick Win Big Bet1 hit
70
The chart uses a color-coded legend to distinguish between Diversified HPC Peers and Skin Health and Beauty Peers.Starboard Value | Activist Presentation Deck | 71 slides · Starboard Value
Activist deck Activist investor Loop · Quick Win Big Bet1 hit
06
The slide uses a visual callout to emphasize the $40bn incremental FCF figure.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor 1 hit
12
The chart uses a dashed box to highlight PFE and a dashed red line to indicate the peer median of 46 drugs.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)Loop · Iceberg1 hit
17
The slide uses a table to track 15 specific drug programs, noting their therapeutic area, next steps, and timing, with symbols indicating status (check for approval, star for designation, box for negative data).Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)Loop · Iceberg1 hit
22
Uses a red arrow annotation to emphasize the gap between projected 2030 sales and the blockbuster threshold.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Agitate (Make it worse)1 hit
36
The chart highlights the divergence in GLP-1 success between the two peers and the implied laggard (Pfizer).Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor 1 hit
38
The chart highlights Pfizer's underperformance relative to peers, including a specific callout for 'PFE Excl. COVID'.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor 1 hit
46
The chart highlights the discrepancy between management's valuation assumptions and consensus expectations.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Loop · Cost Of Inaction1 hit
52
Uses checkmarks and X marks to visualize performance; highlights 2021-2022 as a 'COVID Benefit' period.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor 1 hit
73
The chart includes a specific callout for 'PFE (Median R&D Efficiency)' at the end, suggesting a comparison of valuation vs. efficiency.Starboard Value | Activist Presentation Deck | 74 slides · Starboard Value
Activist deck Activist investor Beat · Solution (Provide relief)1 hit
17
Includes legend for bond types and footnotes regarding scope and methodology.UBS | Results Presentation Deck | 45 slides · UBS
Conference presentation Investor relations Beat · Satisfaction1 hit
23
The slide uses a dot plot visualization to show current ratings and directional arrows to indicate outlooks (negative, stable, developing, positive) or review status.UBS | Results Presentation Deck | 45 slides · UBS
Conference presentation Investor relations Beat · Visualization1 hit
24
The slide uses a dot plot visualization to map credit ratings for 10 financial institutions across three major rating agencies.UBS | Results Presentation Deck | 45 slides · UBS
Conference presentation Investor relations Beat · Visualization1 hit